Abstract

For the local treatment of a number of bowel disorders such as ulcerative colitis, Crohn's disease, amoebiasis and sand, colonic cancer, the local treatment of colonic pathologies, and the systemic distribution of protein and peptide medicines, targeted drug delivery into the colon is extremely desirable. A medication must be properly formulated for colon-focused drug delivery. To ensure sudden or controlled release in the proximal colon, the substance must first be shielded from degradation, release, and absorption in the upper GI tract. The advantages and disadvantages, cutting-edge methods for colon-targeted drug delivery, clinical evaluation methods, and some details about commercial dosage forms are the main topics of this paper

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call